|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 35
Zeitschriftenartikel
Brandl, Felix; Knolle, Franziska; Avram, Mihai; Leucht, Claudia; Yakushev, Igor; Priller, Josef; Leucht, Stefan; Ziegler, Sibylle; Wunderlich, Klaus und Sorg, Christian
(2022):
Negative symptoms, striatal dopamine and model-free reward decision-making in schizophrenia.
In: Brain, Bd. 146, Nr. 2: S. 767-777
Siafis, Spyridon; Bursch, Nicola; Müller, Katharina; Schmid, Lisa; Schuster, Florian; Waibel, Jakob; Huynh, Tri; Matthes, Florian; Rodolico, Alessandro; Brieger, Peter; Buhner, Markus; Heres, Stephan; Leucht, Stefan und Hamann, Johannes
(2022):
Evidence-based Shared-Decision-Making Assistant (SDM-assistant) for choosing antipsychotics: protocol of a cluster-randomized trial in hospitalized patients with schizophrenia.
In: BMC Psychiatry, Bd. 22, Nr. 1, 406
Pielenz, Charline; Schneider, Marco; Salveridou-Hof, Eva; Flick, Marisa; Gaigl, Gabriele; Khorikian-Ghazari, Naiiri; Gueler, Duygu; Halms, Theresa; Kapfhammer, Angelika; Lorenz, Carolin; Roeh, Astrid; Wagner, Elias; Falkai, Peter; Leucht, Stefan; Gaebel, Wolfgang und Hasan, Alkomiet
(2022):
From conventional to living guidelines - faster updates for better informed guidance? A scoping review.
In: Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen, Bd. 174: S. 20-31
Schmidt-Kraepelin, Christian; Feyerabend, Sandra; Engelke, Christina; Riesbeck, Mathias; Meisenzahl-Lechner, Eva; Verde, Pablo-Emilio; Correll, Christoph U.; Kluge, Michael; Makiol, Christian; Neff, Andrea; Lange, Christina; Englisch, Susanne; Zink, Mathias; Langguth, Berthold; Poeppl, Timm B.; Reske, Dirk; Gouzoulis-Mayfrank, Euphrosyne; Gruender, Gerhard; Hasan, Alkomiet; Brockhaus-Dumke, Anke; Jaeger, Markus; Baumgaertner, Jessica; Leucht, Stefan und Cordes, Joachim
(2022):
Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial.
In: Lancet Psychiatry, Bd. 9, Nr. 4: S. 291-306
Wu, Hui; Siafis, Spyridon; Hamza, Tasnim; Schneider-Thoma, Johannes; Davis, John M.; Salanti, Georgia und Leucht, Stefan
(2022):
Antipsychotic-Induced Weight Gain: Dose-Response Meta-Analysis of Randomized Controlled Trials.
In: Schizophrenia Bulletin, Bd. 48, Nr. 3: S. 643-654
Heres, Stephan; Cordes, Joachim; Feyerabend, Sandra; Schmidt-Kraepelin, Christian; Musil, Richard; Riedel, Michael; Spellmann, Ilja; Langguth, Berthold; Landgrebe, Michael; Fran, Elmar; Petcu, Camelia C.; Hahn, Eric; Ta, Tam M. T.; Matei, Valentin; Dehelean, Liana; Papava, Ion; Leweke, F. Markus; List, Till van der; Tamasan, Simona C.; Lang, Fabian U.; Naber, Dieter; Ruhrmann, Stephan; Wolff-Menzler, Claus; Juckel, Georg; Ladea, Maria; Stefanescu, Cristinel; Lautenschlager, Marion; Bauer, Michael; Zamora, Daisy; Horowitz, Mark; Davis, John M. und Leucht, Stefan
(2022):
Changing the Antipsychotic in Early Nonimprovers to Amisulpride or Olanzapine: Randomized, Double-Blind Trial in Patients With Schizophrenia.
In: Schizophrenia Bulletin, Bd. 48, Nr. 6: S. 1273-1283
Lorenz, Carolin; Gaigl, Gabriele; Gueler, Duygu; Halms, Theresa; Khorikian-Ghazari, Naiiri; Roeh, Astrid; Schneider, Marco; Wagner, Elias; Schneider-Axmann, Thomas; Kapfhammer, Angelika; Flick, Marisa; Pielenz, Charline; Salveridou-Hof, Eva; Falkai, Peter; Gaebel, Wolfgang; Hasan, Alkomiet und Leucht, Stefan
(2022):
Structured implementation of digital, systematically updated guideline recommendations for enhanced adherence in schizophrenia (SISYPHOS)-protocol of a cluster-randomized trial.
In: Trials, Bd. 23, Nr. 1, 807
Yoshida, Kazufumi; Seo, Michael; Luo, Yan; Sahker, Ethan; Cipriani, Andrea; Leucht, Stefan; Iwatsubo, Takeshi; Efthimiou, Orestis und Furukawa, Toshiaki A.
(2022):
Personalized Prediction of Alzheimer's Disease and Its Treatment Effects by Donepezil: An Individual Participant Data Meta-Analysis of Eight Randomized Controlled Trials.
In: Journal of Alzheimers Disease, Bd. 89, Nr. 4: S. 1143-1157
Falkai, Peter; Koutsouleris, Nikolaos; Bertsch, Katja; Bialas, Mirko; Binder, Elisabeth; Buehner, Markus; Buyx, Alena; Cai, Na; Cappello, Silvia; Ehring, Thomas; Gensichen, Jochen; Hamann, Johannes; Hasan, Alkomiet; Henningsen, Peter; Leucht, Stefan; Moehrmann, Karl Heinz; Nagelstutz, Elisabeth; Padberg, Frank; Peters, Annette; Pfaeffel, Lea; Reich-Erkelenz, Daniela; Riedl, Valentin; Rueckert, Daniel; Schmitt, Andrea; Schulte-Koerne, Gerd; Scheuring, Elfriede; Schulze, Thomas G.; Starzengruber, Rudolf; Stier, Susanne; Theis, Fabian J.; Winkelmann, Juliane; Wurst, Wolfgang und Priller, Josef
(2022):
Concept of the Munich/Augsburg Consortium Precision in Mental Health for the German Center of Mental Health.
In: Frontiers in Psychiatry, Bd. 13, 815718
Salanti, Georgia; Peter, Natalie; Tonia, Thomy; Holloway, Alexander; White, Ian R.; Darwish, Leila; Low, Nicola; Egger, Matthias; Haas, Andreas D.; Fazel, Seena; Kessler, Ronald C.; Herrman, Helen; Kieling, Christian; De Quervain, Dominique J. F.; Vigod, Simone N.; Patel, Vikram; Li, Tianjing; Cuijpers, Pim; Cipriani, Andrea; Furukawa, Toshi A. und Leucht, Stefan
(2022):
The Impact of the COVID-19 Pandemic and Associated Control Measures on the Mental Health of the General Population A Systematic Review and Dose-Response Meta-analysis.
In: Annals of Internal Medicine, Bd. 175, Nr. 11: S. 1560-1571
Wagner, Elias; Siafis, Spyridon; Fernando, Piyumi; Falkai, Peter; Honer, William G.; Roeh, Astrid; Siskind, Dan; Leucht, Stefan und Hasan, Alkomiet
(2021):
Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review.
In: Translational Psychiatry, Bd. 11, Nr. 1, 487
Leucht, Stefan; Siafis, Spyridon; Engel, Rolf R.; Schneider-Thoma, Johannes; Bighelli, Irene; Cipriani, Andrea; Furukawa, Toshi A. und Davis, John M.
(2021):
How Efficacious Are Antipsychotic Drugs for Schizophrenia? An Interpretation Based on 13 Effect Size Indices.
In: Schizophrenia Bulletin, Bd. 48, Nr. 1: S. 27-36
Leucht, Stefan; Bauer, Sofia; Siafis, Spyridon; Hamza, Tasnim; Wu, Hui; Schneider-Thoma, Johannes; Salanti, Georgia und Davis, John M.
(2021):
Examination of Dosing of Antipsychotic Drugs for Relapse Prevention in Patients With Stable Schizophrenia A Meta-analysis.
In: Jama Psychiatry, Bd. 78, Nr. 11: S. 1238-1248
Gaigl, Gabriele; Taeumer, Esther; Merz, Katharina; Zoescher, Sabina; Wagner, Sarah; Koesters, Markus; Falkai, Peter; Leucht, Stefan und Hasan, Alkomiet
(2021):
Multifactorial barriers in the implementation of schizophrenia and psychosocial therapies guidelines: A quantitative study across different professions.
In: Schizophrenia Research, Bd. 228: S. 425-434
Wagner, Elias; Siafis, Spyridon; Fernando, Piyumi; Falkai, Peter; Honer, William G.; Röh, Astrid; Siskind, Dan; Leucht, Stefan und Hasan, Alkomiet
(2021):
Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review.
In: Translational psychiatry, Bd. 11, 487
[PDF, 2MB]
Hasan, Alkomiet; Roeh, Astrid; Leucht, Stefan; Langguth, Berthold; Hansbauer, Maximilian; Oviedo-Salcedo, Tatiana; Kirchner, Sophie K.; Papazova, Irina; Loehrs, Lisa; Wagner, Elias; Maurus, Isabel; Strube, Wolfgang; Rossner, Moritz J.; Wehr, Michael C.; Bauer, Ingrid; Heres, Stephan; Leucht, Claudia; Kreuzer, Peter M.; Zimmermann, Stephanie; Schneider-Axmann, Thomas; Goerlitz, Thomas; Karch, Susanne; Egert-Schwender, Silvia; Schossow, Beate; Rothe, Philipp und Falkai, Peter
(2020):
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
In: Contemporary Clinical Trials Communications, Bd. 17, 100537
Avram, Mihai; Brandl, Felix; Knolle, Franziska; Cabello, Jorge; Leucht, Claudia; Scherr, Martin; Mustafa, Mona; Koutsouleris, Nikolaos; Leucht, Stefan; Ziegler, Sibylle und Sorg, Christian
(2020):
Aberrant striatal dopamine links topographically with cortico-thalamic dysconnectivity in schizophrenia.
In: Brain, Bd. 143: S. 3495-3505
Furukawa, Toshi A.; Reijnders, Mirjam; Kishimoto, Sanae; Sakata, Masatsugu; DeRubeis, Robert J.; Dimidjian, Sona; Dozois, David J. A.; Hegerl, Ulrich; Hollon, Steven D.; Jarrett, Robin B.; Lesperance, Francois; Segal, Zindel V.; Mohr, David C.; Simons, Anne D.; Quilty, Lena C.; Reynolds, Charles F.; Gentili, Claudio; Leucht, Stefan; Engel, Rolf R. und Cuijpers, Pim
(2020):
Translating the BDI and BDI-II into the HAMD and vice versa with equipercentile linking.
In: Epidemiology and Psychiatric Sciences, Bd. 29, e24
Huhn, Maximilian; Leucht, Claudia; Rothe, Philipp; Dold, Markus; Heres, Stephan; Bornschein, Susanne; Schneider-Axmann, Thomas; Hasan, Alkomiet und Leucht, Stefan
(2020):
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 271, Nr. 2: S. 293-302
Schmidt-Kraepelin, Christian; Feyerabend, Sandra; Engelke, Christina; Riesbeck, Mathias; Meisenzahl-Lechner, Eva; Gaebel, Wolfgang; Verde, Pablo-Emilio; Kolbe, Henrike; Correll, Christoph U.; Leucht, Stefan; Heres, Stephan; Kluge, Michael; Makiol, Christian; Neff, Andrea; Lange, Christina; Englisch, Susanne; Zink, Mathias; Langguth, Berthold; Poeppl, Timm; Reske, Dirk; Gouzoulis-Mayfrank, Euphrosyne; Gruender, Gerhard; Hasan, Alkomiet; Brockhaus-Dumke, Anke; Jaeger, Markus; Baumgaertner, Jessica; Wobrock, Thomas und Cordes, Joachim
(2020):
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 270, Nr. 1: S. 83-94
Brandl, Felix; Avram, Mihai; Weise, Benedikt; Shang, Jing; Simoes, Beatriz; Bertram, Teresa; Ayala, Daniel Hoffmann; Penzel, Nora; Guersel, Deniz A.; Baeuml, Josef; Wohlschlaeger, Afra M.; Vukadinovic, Zoran; Koutsouleris, Nikolaos; Leucht, Stefan und Sorg, Christian
(2019):
Specific Substantial Dysconnectivity in Schizophrenia: A Transdiagnostic Multimodal Meta-analysis of Resting-State Functional and Structural Magnetic Resonance Imaging Studies.
In: Biological Psychiatry, Bd. 85, Nr. 7: S. 573-583
Avram, Mihai; Brandl, Felix; Cabello, Jörge; Leucht, Claudia; Scherr, Martin; Mustafa, Mona; Leucht, Stefan; Ziegler, Sibylle und Sorg, Christian
(2019):
Reduced striatal dopamine synthesis capacity in patients with schizophrenia during remission of positive symptoms.
In: Brain, Bd. 142: S. 1813-1826
Cabello, Jörge; Avram, Mihai; Brandl, Felix; Mustafa, Mona; Scherr, Martin; Leucht, Claudia; Leucht, Stefan; Sorg, Christian und Ziegler, Sibylle I.
(2019):
Impact of non-uniform attenuation correction in a dynamic [F-18]-FDOPA brain PET/MRI study.
In: EJNMMI Research, Bd. 9, Nr. 1, 77
Leucht, Stefan; Fennema, Hein; Engel, Rolf R.; Kaspers-Janssen, Marion und Szegedi, Armin
(2018):
Translating the HAM-D into the MADRS and vice versa with equipercentile linking.
In: Journal of Affective Disorders, Bd. 226: S. 326-331
Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Johannes; Bighelli, Irene; Chaimani, Anna und Leucht, Stefan
(2018):
Efficacy, acceptability, and tolerability of antipsychotics in children and adolescents with schizophrenia: A network meta-analysis.
In: European Neuropsychopharmacology, Bd. 28, Nr. 6: S. 659-674
Schneider-Thoma, Johannes; Efthimiou, Orestis; Huhn, Maximilian; Krause, Marc; Reichelt, Leonie; Röder, Hannah; Davis, John M.; Salanti, Georgia und Leucht, Stefan
(2018):
Second-generation antipsychotic drugs and short-term mortality: a systematic review and meta-analysis of placebo-controlled randomised controlled trials.
In: Lancet Psychiatry, Bd. 5, Nr. 8: S. 653-663
Krause, Marc; Huhn, Maximilian; Schneider-Thoma, Johannes; Rothe, Philipp; Smith, Robert C. und Leucht, Stefan
(2018):
Antipsychotic drugs for elderly patients with schizophrenia: A systematic review and meta-analysis.
In: European Neuropsychopharmacology, Bd. 28, Nr. 12: S. 1360-1370
Krause, Marc; Zhu, Yikang; Huhn, Maximilian; Schneider-Thoma, Johannes; Bighelli, Irene; Nikolakopoulou, Adriani und Leucht, Stefan
(2018):
Antipsychotic drugs for patients with schizophrenia and predominant or prominent negative symptoms: a systematic review and meta-analysis.
In: European Archives of Psychiatry and Clinical Neuroscience, Bd. 268, Nr. 7: S. 625-639
Leucht, Stefan; Fennema, Hein; Engel, Rolf R.; Kaspers-Janssen, Marion; Lepping, Peter und Szegedi, Armin
(2017):
What does the MADRS mean? Equipercentile linking with the CGI using a company database of mirtazapine studies.
In: Journal of Affective Disorders, Bd. 210: S. 287-293
Schreiter, Stefanie; Bermpohl, Felix; Krausz, Michael; Leucht, Stefan; Roßler, Wulf; Schouler-Ocak, Meryam und Gutwinski, Stefan
(2017):
The Prevalence of Mental Illness in Homeless People in Germany. A Systematic Review and Meta-analysis.
In: Deutsches Ärzteblatt international, Bd. 114, Nr. 40: S. 665-672
Wang, Yijun; Xia, Jun; Helfer, Bartosz; Li, Chunbo und Leucht, Stefan
(2016):
Valproate for schizophrenia.
In: Cochrane Database of Systematic Reviews, Nr. 11, CD004028
Leucht, Stefan; Samara, Myrto; Heres, Stephan und Davis, John M.
(2016):
Dose Equivalents for Antipsychotic Drugs: The DDD Method.
In: Schizophrenia Bulletin, Bd. 42:
S90-S94
Heilbronner, Urs; Samara, Myrto; Leucht, Stefan; Falkai, Peter 
ORCID: https://orcid.org/0000-0003-2873-8667 und Schulze, Thomas G.
(2016):
The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects.
In: Harvard Review of Psychiatry, Bd. 24, Nr. 2: S. 118-128
ORCID: https://orcid.org/0000-0003-2873-8667 und Schulze, Thomas G.
(2016):
The Longitudinal Course of Schizophrenia Across the Lifespan: Clinical, Cognitive, and Neurobiological Aspects.
In: Harvard Review of Psychiatry, Bd. 24, Nr. 2: S. 118-128
Koutsouleris, Nikolaos; Kahn, René S.; Chekroud, Adam M.; Leucht, Stefan; Falkai, Peter ORCID: https://orcid.org/0000-0003-2873-8667; Wobrock, Thomas; Derks, Eske M.; Fleischhacker, Wolfgang W. und Hasan, Alkomiet
(2016):
Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach.
In: Lancet Psychiatry, Bd. 3, Nr. 10: S. 935-946
ORCID: https://orcid.org/0000-0003-2873-8667; Wobrock, Thomas; Derks, Eske M.; Fleischhacker, Wolfgang W. und Hasan, Alkomiet
(2016):
Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach.
In: Lancet Psychiatry, Bd. 3, Nr. 10: S. 935-946
Helfer, Bartosz; Samara, Myrto T.; Huhn, Maximilian; Klupp, Elisabeth; Leucht, Claudia; Zhu, Yikang; Engel, Rolf R. und Leucht, Stefan
(2016):
Efficacy and Safety of Antidepressants Added to Antipsychotics for Schizophrenia: A Systematic Review and Meta-Analysis.
In: American Journal of Psychiatry, Bd. 173, Nr. 9: S. 876-886